Where does Bioniz, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bioniz, LLC ranks #20,835 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bioniz, LLC hold?

Bioniz, LLC holds 13 US utility patents granted between 2015 and 2023, spanning 8 technology areas.

What is Bioniz, LLC's Innovation Score?

Bioniz, LLC has an Innovation Score of 33.9 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioniz, LLC focus on?

Bioniz, LLC's top technology area is C07K (Peptides) with 10 patents, ranking #887 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Bioniz, LLC's patent grant rate increasing or decreasing?

Bioniz, LLC's recent grant velocity is -37% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Bioniz, LLC's patents?

Bioniz, LLC's patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bioniz, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bioniz, LLC

USPTO PatentsView assignee record - 13 granted patents across 8 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bioniz ranks #20,835 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 8 technology areas.

#20,835
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.9/100): 13.5
avg claims per patent: -37%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20835 · US Corporation #20,835 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,835/49,997
PHOTO-FINISH Bioelectron Technology
CPC-NARROW C07K · 8 areas
INNOV-THIN 33.9/100
CLAIMS-RICH 13.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -37% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bioelectron Technology Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bioniz’s 33.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (27%) Velocity 6.7 pts (20%) Breadth 10.0 pts (29%) Claim depth 8.1 pts (24%)

Qualcomm Incorporated · highest

85
Bioniz · this assignee

34
3D Lighting… · lowest

7

What this shows Bioniz's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bioniz?

Each dot is one of Bioniz’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioniz’s own 13.5 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bioniz vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bioniz's grants concentrate

Bioniz, LLC is a focused PatentsView assignee: 8 CPC subclasses with 76.9% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2017. By volume, Bioniz sits between Bioelectron Technology Corporation and Blum-novotest GMBH.

Bioniz's three-year grant acceleration

Bioniz, LLC shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bioelectron Techn…

13
Biofreeze IP Hold…

13
Biogen Chesapeake

13
Biogen Idec MA

13
Bitanimate

13
Bizlink Industry…

13
Black & Veatch

13
Blum-novotest

13
Bioniz ◀

13

What this shows Bioniz holds 13 patents at rank #20,819, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioniz

By rank, the assignees closest to #20,819 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Bioniz's primary technology class.

Bioniz's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bioniz, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	15.4%
2017	1	7.7%
2018	4	30.8%
2019	1	7.7%
2020	2	15.4%
2022	2	15.4%
2023	1	7.7%

Which technologies does Bioniz, LLC patent most?

C07K - Peptides 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 3

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bioniz, LLC's patent record in context - here's where to go next.

Bioniz, LLC's lead technology class is C07K (Peptides), 76.9% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #20,835 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bioniz, LLC against Bioelectron Technology Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.